0001209191-19-032589.txt : 20190524
0001209191-19-032589.hdr.sgml : 20190524
20190524101135
ACCESSION NUMBER: 0001209191-19-032589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190523
FILED AS OF DATE: 20190524
DATE AS OF CHANGE: 20190524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDBERG MURRAY A
CENTRAL INDEX KEY: 0001226435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 19852394
MAIL ADDRESS:
STREET 1: 2030 MAIN STREET, SUITE 1500
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-23
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001226435
GOLDBERG MURRAY A
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2019-05-23
4
A
0
1750
0.00
A
8050
D
Stock Option (right to buy)
39.44
2019-05-23
4
A
0
7800
0.00
A
2029-05-23
Common Stock
7800
7800
D
Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020.
Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019.
/s/ John LaRocca, Attorney-in-Fact for Murray A. Goldberg
2019-05-23
EX-24.4_855642
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints Vicente Anido, Jr., Richard J. Rubino, and John LaRocca, and each of
them, with full power of substitution, the undersigned's true and lawful
attorneys-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as executive officer and/or director of Aerie Pharmaceuticals, Inc. (the
"Company"), any forms required to be filed by the undersigned pursuant to Rule
144 under the Securities Act of 1933, as amended (the "Securities Act"), or
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, and any
other forms or reports the undersigned may be required to file in connection
with the undersigned's ownership, acquisition, or disposition of securities of
the Company;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such forms required to
be filed by the undersigned pursuant to Rule 144 under the Securities Act or any
such Form 3, 4, or 5, or other form or report, including, without limitation,
all forms or reports necessary to obtain EDGAR Identification Numbers, and
timely file such form or report with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of any such attorney-in-fact, may be of benefit
to, in the best interests of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming any
of the undersigned's responsibilities to comply with either Rule 144 under the
Securities Act or Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file any forms required to be filed by the
undersigned pursuant to Rule 144 under the Securities Act or Forms 3, 4, and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 7th day of June, 2018.
/s/ Murray A. Goldberg
Murray A. Goldberg